World's Best Scientists 2026 revealed!
Peptides
H-index 26

Peptides

0196-9781

Published by: Elsevier

https://www.journals.elsevier.com/peptides

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1202 80 133 20

Additional Metrics

Number of Best Scientists*: 194
Documents by Best Scientists*: 258
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 144
SCIMAGO SJR: 0.958
Impact Factor: 2.9

Overview

Top Research Topics at Peptides?

The journal focuses largely on the fields of Internal medicine, Endocrinology, Receptor, Biochemistry and Peptide. The journal covers various topics on Internal medicine such as Neuropeptide, Hormone, Agonist, Cholecystokinin and Vasoactive intestinal peptide. Substance P is a major topic of Neuropeptide research.

The journal addresses concerns in Endocrinology which are intertwined with other disciplines, such as Antagonist and Neuropeptide Y receptor. The research on Receptor featured in it combines topics in other fields like Signal transduction, Cell biology, Pharmacology and Binding site. The journal focuses on Biochemistry as well as the interrelated topic of Molecular biology.

Topics in Peptide were tackled in line with various other fields like Antimicrobial and Stereochemistry. Antimicrobial peptides research discussed in Peptides aim to provide more information in the subject of Microbiology.

  • Internal medicine (59.80%)
  • Endocrinology (58.63%)
  • Receptor (20.62%)

What are the most cited papers published in the journal?

  • Leptin enters the brain by a saturable system independent of insulin. (1097 citations)
  • Antioxidative peptides from food proteins: a review (979 citations)
  • Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology (879 citations)

Research areas of the most cited articles at Peptides:

The most cited articles focus largely on the fields of Internal medicine, Endocrinology, Biochemistry, Receptor and Peptide. Issues in Endocrinology were discussed in the published papers, taking into consideration concepts from other disciplines like Neuropeptide and Neuropeptide Y receptor. The journal publications explore topics in Receptor which can be helpful for research in disciplines like Signal transduction, Cell biology, Pharmacology and Binding site.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

Peptides is mainly concerned with subjects like Internal medicine, Endocrinology, Receptor, Peptide and Cell biology. It links adjacent topics like Internal medicine with Cardiology. The Endocrinology research presented in Peptides explores the relationship between Inflammation and the closely related topic of Gene expression.

It focuses on Receptor but sometimes tackles the closely related topic of Pharmacology which is concerned with Toxicity. While the primary focus in the journal is Peptide, it also dissects topics surrounding In vitro and In vivo as a whole. It facilitates discussions on Cell biology that incorporate concepts from other fields like Gene and Immune system.

The most cited articles from the last journal are:

  • Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality. (6 citations)
  • Antiviral peptides against Coronaviridae family: A review. (5 citations)
  • Nisin-A lantibiotic with immunomodulatory properties: A review. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Peptides (based on the number of publications) are:

  • J. Michael Conlon (95 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Hubert Vaudry (93 papers) absent at the last edition,
  • Ronald J. Nachman (89 papers) published 1 paper at the last edition,
  • Abba J. Kastin (83 papers) absent at the last edition,
  • David H. Coy (62 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Peptides (based on the number of publications) are:

  • National Institutes of Health (263 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Tulane University (239 papers) absent at the last edition,
  • French Institute of Health and Medical Research (164 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Veterans Health Administration (158 papers) published 1 paper at the last edition the same number as at the previous edition,
  • University of California, Los Angeles (147 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.06% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 6.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.33% of all publications and 68.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities and Education for Aspiring Peptide Researchers

In order to engage in the study of peptides and related disciplines in academic journals such as this one, a strong educational background is required. This starts at the undergraduate level, but truly builds and solidifies with postgraduate studies. Therefore, we intend to provide guidance for those interested in advancing their career in peptides research through educational opportunities. The study fields such as biochemistry, internal medicine, and endocrinology, etc., are integral disciplines in peptides research. These fields usually have prerequisite education paths starting from related undergraduate studies. Most importantly, prospective peptides researchers must have a strong understanding of human physiology and related laboratory techniques, which can best be obtained through an appropriate educational institution that offers specified programs in these areas. One such location where students interested in these paths can find some of the **best nursing schools in New Hampshire**. These programs offer comprehensive courses in physiology and laboratory techniques, alongside medical knowledge that can become a stepping stone into the research world of peptides. In conclusion, the beginning of an academic career in peptides research requires building a solid educational foundation. This article provides insight into the required educational steps, the disciplines involved in peptides research, and some of the educational opportunities available. Therefore, prospective peptides researchers now have a guide for their educational journey.

Top Publications

  • An update on peptide-based therapies for type 2 diabetes and obesity

    (2023)
    101 Citations
  • Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists

    Lærke S. Gasbjerg;Natasha C. Bergmann;Signe Stensen;Mikkel B. Christensen

    (2020)
    91 Citations
  • GIP has neuroprotective effects in Alzheimer and Parkinson's disease models.

    Zhen Qiang Zhang;Christian Hölscher

    (2020)
    62 Citations
  • The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)

    Sravan K. Thondam;Daniel J. Cuthbertson;John P.H. Wilding

    (2020)
    53 Citations
  • GIP analogues and the treatment of obesity-diabetes

    Clifford J. Bailey

    (2020)
    43 Citations
  • Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease

    Sebastian M. Heimbürger;Natasha C. Bergmann;Robert Augustin;Lærke S. Gasbjerg

    (2020)
    41 Citations
  • NUCB2/nesfatin-1 - Inhibitory effects on food intake, body weight and metabolism.

    Martha A. Schalla;Suraj Unniappan;Nils W.G. Lambrecht;Masatomo Mori

    (2020)
    38 Citations
  • Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates

    Patrick J. Knerr;Stephanie A. Mowery;Brian Finan;Diego Perez-Tilve

    (2020)
    36 Citations
  • Apelin Pathway in Cardiovascular, Kidney, and Metabolic Diseases: Therapeutic role of Apelin Analogs and Apelin Receptor Agonists.

    Amanda A. de Oliveira;Ander Vergara;Xiaopu Wang;John C. Vederas

    (2021)
    33 Citations
  • GIP and the gut-bone axis - Physiological, pathophysiological and potential therapeutic implications.

    Signe Stensen;Lærke Smidt Gasbjerg;Mads Marstrand Helsted;Bolette Hartmann

    (2020)
    31 Citations

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or complementary career paths, numerous online degree options can provide flexibility and advancement opportunities. Many registered nurses choose to advance their qualifications through an online bsn programs that offer affordable routes from a Bachelor of Science in Nursing (BSN) to a Master of Science in Nursing (MSN). These programs help nurses elevate their expertise without disrupting their work-life balance.

If clinical hours pose a scheduling challenge, there are online rn to bsn no clinicals programs specifically designed to eliminate clinical requirements, making degree completion more convenient for working professionals.

For ambitious students aiming for the highest nursing qualifications quickly, the fastest bsn to dnp program options focus on expedited paths from BSN to Doctor of Nursing Practice (DNP), facilitating advanced clinical leadership roles in less time.

Those considering allied health careers can explore medical assistant training, which offers accelerated programs that prepare students for certification and entry-level roles in healthcare settings within just a few weeks.

Exploring these related online degrees ensures that future healthcare professionals can find pathways suited to their goals and lifestyles, broadening their impact in the medical field.

Best Scientists Contributing to This Journal